Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page
- CheckyesterdayChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operations, with guidance to check opm.gov for status updates. Updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check8 days agoChange DetectedAdded a Show glossary toggle and updated QC metadata (Last Update Submitted that Met QC Criteria) with Revision: v3.4.0, while removing the prior lowercase label, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page footer. This is a minor site update and does not change the study details or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedLocations are now listed under a single Locations section with sites across US states and Canadian provinces; the page shows a Revision: v3.3.3.SummaryDifference2%

- Check66 days agoChange DetectedRevision: v3.3.2 has been added and the previous v3.3.1 revision has been removed.SummaryDifference0.0%

- Check73 days agoChange DetectedAdded a note that publications are automatically pulled from PubMed and may not relate to the study, and updated the revision to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.